Dr. Micha Abeles, M.D., who is an experienced rheumatologist, discusses how recent studies have discovered a potential connection between the use of arthritis drugs and Alzheimer's Disease prevention.
2. chronic
rheumatoid
arthritis
are well aware of the benefits that
arthritis medication presents. But it
turns out that arthritis medication
may not just help soothe aching
joints. It may, according to recent
data, play a part in helping to deter
Alzheimer’s Disease.
People who have
3. Oxford University and
NIHR Southampton
Biomedical Research
Centre
analyzed over 5,800 people living with
arthritis. They compared 3,876 patients who
took disease-modifying anti-rheumatic drugs
(DMARDs), particularly the medication
methotrexate, with 1,938 patients who
abstained from the medication. The results?
Well, to the surprise of many, turn out to be
promising when it comes to the ability of
Arthritis drugs in producing results outside of
their domain of specification.
A study by
4. The study concluded the people on the anti-inflammatory
medication had approximately half the risk of developing
Alzheimer’s disease and other forms of dementia. The findings,
which were published in the journal Alzheimer’s And Dementia:
Translational Research And Clinical Interventions, truly served as
good news for many, and the research appears, to many
healthcare professionals, to be quite indicative of the benefit of
Alzheimer’s medication.
Interpreting the Data
5. Rheumatoid arthritis affects approximately 1.5 million Americans
and about 5.5 million Americans have Alzheimer’s disease. NIHR
Southampton Biomedical Research Centre professor, Chris
Edwards said: “The results we’ve seen make us optimistic that we
are getting closer to better treating this neurological disease and
supports further investigation in clinical trials to confirm if these
drugs can be used to prevent or treat dementia.”
6. Alzheime
r's
Currently, there is not a cure for Alzheimer’s disease, so these
findings are extremely fascinating for those actively searching
for a lasting remedy, as well as for the millions of people
enduring this disease.
Alzheimer’s Society is now funding Queen’s University
professor, Dr. Bernadette McGuiness, to continue this research.
McGuiness, who is working with Chris Edwards to further this
promising research, is looking at a group of drugs for arthritis
that could be repurposed to help reduce certain inflammation
that is often tied to the occurrence of Alzheimer’s disease. While
the results are still far from conclusive, they are certainly well-
documented, as well as promising for many.
Continuing the
Research on